Low-Carbohydrate Diet May Be Associated With Lower Risk of Blinding Eye Disease
Adhering to long-term dietary changes could lead to fewer cases of a common glaucoma subtype
Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may lower the risk of the most common subtype of glaucoma. In a first-of-its-kind study, a researcher at New York Eye and Ear Infirmary of Mount Sinai (NYEE) helped discover that if at-risk groups adhere to these dietary restrictions, they may reduce their risk of developing primary open angle glaucoma with early paracentral visual loss by 20 percent. Results from the research have been published in the July 22 issue of Eye-Nature.
The study is important because glaucoma is the leading cause of blindness in the United States and primary open angle glaucoma (POAG) is the most common type. POAG is the leading cause of optic nerve degeneration that is related to the pressure level inside the eye, but other factors also contribute to this condition. Patients typically experience few or no symptoms until the disease progresses and they have vision loss.
“A diet low in carbohydrates and higher in fats and proteins results in the generation of metabolites favorable for the mitochondrion-rich optic nerve head, which is the site of damage in POAG. This dietary pattern has already been shown to have favorable results for epilepsy and showed some promising results for Parkinson’s and Alzheimer’s diseases,” said co-corresponding author Louis R. Pasquale, MD, FARVO, Deputy Chair for Ophthalmology Research for the Mount Sinai Health System. “It’s important to note that a low-carbohydrate diet won’t stop glaucoma progression if you already have it, but it may be a means to preventing glaucoma in high-risk groups. If more patients in these high-risk categories—including those with a family history of glaucoma—adhered to this diet, there might be fewer cases of vision loss.”
Past studies have shown that a ketogenic diet (low-carbohydrate and high-fat) has a protective effect against neurologic disorders. Ketone bodies (energy compounds produced as the body metabolizes fats) are substituted for glucose as a major energy source for the brain and using more of these under a ketogenic diet may improve function and slow down neuronal degeneration. However, more recent studies have shown that a low-carbohydrate diet that does not restrict protein or total calories may have similar neuroprotective properties; this diet has been recognized as a more practical alternative to a ketogenic diet, as it’s easier to follow and does not have the adverse effects of the ketogenic diet (which range from headache, weakness, and irritability to constipation, nausea, and vomiting).
A team of researchers wanted to know if a low-carbohydrate diet could positively impact the optic nerve. The optic nerve sits in the back of the eye and transfers visual information from the retina to the brain through electrical impulses. The optic nerve has a large concentration of mitochondria (mitochondria represent the major source of a cell's energy supply and lead to a cell’s survival), and has high-energy requirements. Since glaucoma is a condition that may be associated with mitochondrial dysfunction, researchers wanted to find out if substituting protein and fat for carbohydrates in the diet would enhance mitochondrial activity, maintain optic nerve function, and prevent optic nerve degeneration in this blinding eye disease. They performed a large-scale meta-analysis to get this answer.
They followed 185,000 adult participants from three large studies in the United States, conducted between 1976 and 2017. Participants were female nurses and male health professionals between the ages of 40 and 75. Every two to four years, they filled out food frequency questionnaires that assessed what they ate and drank. They also answered questions about their health and what diseases, if any, they might be developing. If they said they had glaucoma, the researchers asked their treating eye care providers to send medical records to determine if they had POAG.
The research team created statistical models based on the patients’ questionnaire responses, dividing them into groups based on carbohydrate intake, so they could look across the spectrum from high to low carbohydrate intake and see any possible relationship with POAG. They specifically looked at three different ways of achieving a low-carbohydrate diet: substituting animal-based fats and proteins for carbohydrates; substituting plant-based based fats and proteins for carbohydrates; and replacing carbohydrates with high fats and proteins regardless of the source. Researchers then calculated the relative risk of POAG after adjusting for multiple factors for each of the dietary patterns including age, race, and body mass index.
Patients in the low-carbohydrate intake group who followed a diet of increased plant-based fat and protein were associated with a 20 percent lower risk of developing POAG subtype with paracentral visual field loss compared to those in the high-carbohydrate intake group. However, the researchers did not find any association between POAG and a low-carbohydrate diet without accounting for the source protein or fat, and they did not find any association between glaucoma and an animal-based low-carbohydrate diet. Their findings suggest vegetable sources may be more beneficial than animal sources for a low-carbohydrate diet with respect to reducing risk of the specific glaucoma subtype with early paracentral visual loss.
“This was an observational study and not a clinical trial, so more work is needed as this is the first study looking at this dietary pattern in relation to POAG. The next step is to use artificial intelligence to objectively quantify paracentral visual loss in our glaucoma cases and repeat the analysis,” adds Dr. Pasquale. “It’s also important to identify patients who have a genetic makeup of primary open angle glaucoma who may benefit from a low-carbohydrate diet. This dietary pattern may be protective only in people with a certain genetic makeup.”
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai advances medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture ambulatory surgery centers; more than 415 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. The Mount Sinai Hospital is ranked on U.S. News & World Report's "Honor Roll" of the top 20 U.S. hospitals and is top in the nation by specialty: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. Mount Sinai Kravis Children's Hospital is ranked in U.S. News & World Report’s “Best Children’s Hospitals” among the country’s best in four out of 10 pediatric specialties. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and No. 14 in the nation for National Institutes of Health funding. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.